Conventional treatments for oral submucous fibrosis were usually prolonged, with a impractical remission mainly due to relapse or poor patient compliance. Mainstay of treatment is concentrated on attempts to improve mouth opening and relieve the associate symptoms by medical and surgical means. 10 patients diagnosed with oral submucous fibrosis were included in the study, all the patients were subjected to triple regimen and followed over a period of 6 months. Amnion with its exceptional wound modulating properties have explored its potentiality in the field of regenerative medicine by acting as a natural scaffold for wound healing, adding on triple regimen made it an excellent candidate for tissue engineering. The purpose of the present study is to call the attention towards the capacity of triple regimen for the successful outcome in the cases of oral submucous fibrosis.
Anusha kollu, R. Sudhir, Nandha kishore and M. Yashwanth. Triple Regimen for Oral Submucous Fibrosis: Our Institutional Experience in a Series of 10 Cases.
DOI: https://doi.org/10.36478/10.36478/makrjms.2025.1.385.393
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2025.1.385.393